Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...
The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback